Cite
Manders SH, van de Laar MA, Rongen-van Dartel SA, et al. Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry. RMD Open. 2015;1(1):e000147doi: 10.1136/rmdopen-2015-000147.
Manders, S. H., van de Laar, M. A., Rongen-van Dartel, S. A., Bos, R., Visser, H., Brus, H. L., Jansen, T., Vonkeman, H. E., van Riel, P. L., & Kievit, W. (2015). Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry. RMD open, 1(1), e000147. https://doi.org/10.1136/rmdopen-2015-000147
Manders, Sofie H M, et al. "Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry." RMD open vol. 1,1 (2015): e000147. doi: https://doi.org/10.1136/rmdopen-2015-000147
Manders SH, van de Laar MA, Rongen-van Dartel SA, Bos R, Visser H, Brus HL, Jansen T, Vonkeman HE, van Riel PL, Kievit W. Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry. RMD Open. 2015 Oct 08;1(1):e000147. doi: 10.1136/rmdopen-2015-000147. eCollection 2015. PMID: 26535151; PMCID: PMC4623370.
Copy
Download .nbib